View More Recent Stories

Nov 10, 2016 07:05AM Biostage Reports 2016 Third Quarter Financial Results and Provides Business Update
Nov 3, 2016 07:05AM Biostage to Host 2016 Third Quarter Update Conference Call
Oct 6, 2016 04:11PM Biostage (BSTG) Says FDA Requests It to Extend Pre-Clinical Large-Animal Safety Study for Cellspan Esophageal Implant
Oct 6, 2016 04:09PM Biostage Provides Regulatory Update of Cellspan™ Esophageal Implant
Sep 29, 2016 07:30AM Biostage to Present at the Cell & Gene Meeting on the Mesa
Sep 14, 2016 08:00AM Biostage to Present at the 2016 Aegis Growth Conference
Aug 24, 2016 07:00AM Biostage to Present at the 18th Annual Rodman & Renshaw Global Investment Conference on September 12, 2016
Aug 22, 2016 07:00AM Biostage Receives Two National Instruments (NI) Engineering Impact Awards for Cellframe™ Technology
Jul 28, 2016 01:13PM Bioengineered Organ Implant Developer Biostage to Host Q2 Update Call Thursday, August 11th at 9:00 am ET
Jul 21, 2016 08:56AM Biostage Appoints Harout DerSimonian, Ph.D. as Chief Scientific Officer to Oversee Cell Biology, Materials Science and Other Research Underlying its Organ Implant Development
Jun 29, 2016 08:23AM Biostage Files for FDA Orphan Drug Designation for Cellspan™ Esophageal Implant
Jun 21, 2016 12:21PM Biostage CEO Provides Mid-Year Update to Shareholders
May 19, 2016 03:08PM Bioengineered Organ Implant Developer Biostage to Present at Marcum and LD Micro Investor Conferences on June 2nd in NYC and June 7th in LA
May 12, 2016 07:32AM Biostage (BSTG) Announces Groundbreaking Data from Cellspan Study with Mayo Clinic
May 12, 2016 07:31AM Biostage Successfully Regenerates Esophagus in Groundbreaking Pre-Clinical Work with Mayo Clinic; Data Provides 'Proof of Concept' to Seek FDA Approval for Clinical Trials
May 3, 2016 10:45AM Bioengineered Organ Implant Developer Biostage to Host Pre-Clinical Research Update and Q1 Call Thursday, May 12th at 9:00 am ET
View More Recent Stories